Matthew Joseph Reed, Sean Comeau, Todd R Wojtanowicz, Bharat Reddy Sampathi, Sofia Penev, Robert Bota
{"title":"病例报告:氯丙嗪与深静脉血栓形成。","authors":"Matthew Joseph Reed, Sean Comeau, Todd R Wojtanowicz, Bharat Reddy Sampathi, Sofia Penev, Robert Bota","doi":"10.1108/MIJ-10-2019-0005","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Since the development of antipsychotic drugs in the 1950s, a variety of studies and case reports have been published that suggest an association between exposure to typical antipsychotics and venous thromboembolisms (VTE). Therefore, when starting treatment with antipsychotics, especially low-potency typical antipsychotics and clozapine, health-care providers must account for the patient's existing VTE risk factors.</p><p><strong>Design/methodology/approach: </strong>In this case report, the authors describe the development of a pulmonary embolism associated with use of chlorpromazine in the treatment of an acute manic episode in a 51-year-old female patient with bipolar disorder type 1.</p><p><strong>Findings: </strong>The patient was brought to the emergency room by the police on a legal hold for bizarre behaviors at a bus stop, which included incessantly yelling at bystanders. The patient was found to have disorganized thoughts, poor sleep, rapid speech, labile mood, distractibility, auditory hallucinations and grandiose delusions. During the course of her stay, the patient received extensive IM chlorpromazine for extreme agitation, in addition to chlorpromazine 200 mg IM Q8H, which was later decreased to chlorpromazine 100 mg chlorpromazine IM/PO Q8H. On day 4 of the treatment, the patient experienced difficulty breathing, hypoxia and tachycardia and was found to have bilateral expiratory wheezes. CT angiography showed sub-segmental pulmonary embolus and the patient was transferred to MICU service. The patient was then intubated and started on heparin by the medical team. Over the course of the next day, her respiratory distress resolved and the patient was extubated.</p><p><strong>Originality/value: </strong>It is possible that chlorpromazine may indeed increase VTEs, and there are various physiological postulations regarding the mechanism of action. However, multiple confounding variables existed in the authors' report, including venous stasis and the use of restraints, tobacco and valproic acid. Each of these variables has been shown to increase VTE occurrence. Further controlled studies are necessary to identify the true relationship between antipsychotics and VTEs.</p>","PeriodicalId":44029,"journal":{"name":"Mental Illness","volume":"11 2","pages":"16-19"},"PeriodicalIF":9.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1108/MIJ-10-2019-0005","citationCount":"3","resultStr":"{\"title\":\"Case report: Chlorpromazine and deep venous thrombosis.\",\"authors\":\"Matthew Joseph Reed, Sean Comeau, Todd R Wojtanowicz, Bharat Reddy Sampathi, Sofia Penev, Robert Bota\",\"doi\":\"10.1108/MIJ-10-2019-0005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Since the development of antipsychotic drugs in the 1950s, a variety of studies and case reports have been published that suggest an association between exposure to typical antipsychotics and venous thromboembolisms (VTE). Therefore, when starting treatment with antipsychotics, especially low-potency typical antipsychotics and clozapine, health-care providers must account for the patient's existing VTE risk factors.</p><p><strong>Design/methodology/approach: </strong>In this case report, the authors describe the development of a pulmonary embolism associated with use of chlorpromazine in the treatment of an acute manic episode in a 51-year-old female patient with bipolar disorder type 1.</p><p><strong>Findings: </strong>The patient was brought to the emergency room by the police on a legal hold for bizarre behaviors at a bus stop, which included incessantly yelling at bystanders. The patient was found to have disorganized thoughts, poor sleep, rapid speech, labile mood, distractibility, auditory hallucinations and grandiose delusions. During the course of her stay, the patient received extensive IM chlorpromazine for extreme agitation, in addition to chlorpromazine 200 mg IM Q8H, which was later decreased to chlorpromazine 100 mg chlorpromazine IM/PO Q8H. On day 4 of the treatment, the patient experienced difficulty breathing, hypoxia and tachycardia and was found to have bilateral expiratory wheezes. CT angiography showed sub-segmental pulmonary embolus and the patient was transferred to MICU service. The patient was then intubated and started on heparin by the medical team. Over the course of the next day, her respiratory distress resolved and the patient was extubated.</p><p><strong>Originality/value: </strong>It is possible that chlorpromazine may indeed increase VTEs, and there are various physiological postulations regarding the mechanism of action. However, multiple confounding variables existed in the authors' report, including venous stasis and the use of restraints, tobacco and valproic acid. Each of these variables has been shown to increase VTE occurrence. Further controlled studies are necessary to identify the true relationship between antipsychotics and VTEs.</p>\",\"PeriodicalId\":44029,\"journal\":{\"name\":\"Mental Illness\",\"volume\":\"11 2\",\"pages\":\"16-19\"},\"PeriodicalIF\":9.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1108/MIJ-10-2019-0005\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mental Illness\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1108/MIJ-10-2019-0005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/11/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mental Illness","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1108/MIJ-10-2019-0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/11/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 3
摘要
目的:自20世纪50年代抗精神病药物开发以来,已发表的各种研究和病例报告表明,暴露于典型抗精神病药物与静脉血栓栓塞(VTE)之间存在关联。因此,当开始使用抗精神病药物,特别是低效典型抗精神病药物和氯氮平治疗时,卫生保健提供者必须考虑到患者现有的静脉血栓栓塞危险因素。设计/方法/方法:在本病例报告中,作者描述了一名51岁女性双相情感障碍1型患者在治疗急性躁狂发作时使用氯丙嗪相关的肺栓塞的发展。调查结果:这名病人被警察带到了急诊室,因为他在一个公共汽车站的奇怪行为,包括不停地对路人大喊大叫。患者有思想混乱、睡眠不好、语速快、情绪不稳定、注意力不集中、幻听和浮夸妄想。住院期间,因极度躁动,患者在服用氯丙嗪200 mg IM Q8H的基础上,广泛应用氯丙嗪IM Q8H,后降至氯丙嗪100 mg氯丙嗪IM/PO Q8H。治疗第4天,患者出现呼吸困难、缺氧、心动过速,并发双侧呼气喘息。CT血管造影显示亚节段性肺栓塞,患者被转移到MICU服务。然后由医疗小组给病人插管并开始使用肝素。在第二天的过程中,她的呼吸窘迫消退,病人拔管。原创性/价值:氯丙嗪可能确实会增加静脉血栓栓塞,关于其作用机制有各种生理假设。然而,在作者的报告中存在多个混杂变量,包括静脉停滞和使用约束、烟草和丙戊酸。这些变量中的每一个都被证明会增加静脉血栓栓塞的发生。进一步的对照研究是必要的,以确定抗精神病药物和静脉血栓栓塞之间的真正关系。
Case report: Chlorpromazine and deep venous thrombosis.
Purpose: Since the development of antipsychotic drugs in the 1950s, a variety of studies and case reports have been published that suggest an association between exposure to typical antipsychotics and venous thromboembolisms (VTE). Therefore, when starting treatment with antipsychotics, especially low-potency typical antipsychotics and clozapine, health-care providers must account for the patient's existing VTE risk factors.
Design/methodology/approach: In this case report, the authors describe the development of a pulmonary embolism associated with use of chlorpromazine in the treatment of an acute manic episode in a 51-year-old female patient with bipolar disorder type 1.
Findings: The patient was brought to the emergency room by the police on a legal hold for bizarre behaviors at a bus stop, which included incessantly yelling at bystanders. The patient was found to have disorganized thoughts, poor sleep, rapid speech, labile mood, distractibility, auditory hallucinations and grandiose delusions. During the course of her stay, the patient received extensive IM chlorpromazine for extreme agitation, in addition to chlorpromazine 200 mg IM Q8H, which was later decreased to chlorpromazine 100 mg chlorpromazine IM/PO Q8H. On day 4 of the treatment, the patient experienced difficulty breathing, hypoxia and tachycardia and was found to have bilateral expiratory wheezes. CT angiography showed sub-segmental pulmonary embolus and the patient was transferred to MICU service. The patient was then intubated and started on heparin by the medical team. Over the course of the next day, her respiratory distress resolved and the patient was extubated.
Originality/value: It is possible that chlorpromazine may indeed increase VTEs, and there are various physiological postulations regarding the mechanism of action. However, multiple confounding variables existed in the authors' report, including venous stasis and the use of restraints, tobacco and valproic acid. Each of these variables has been shown to increase VTE occurrence. Further controlled studies are necessary to identify the true relationship between antipsychotics and VTEs.